What Is Zepbound? A Complete Guide to Tirzepatide for Weight Loss

Zepbound (tirzepatide) is a once-weekly injectable medication FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related health condition. It works by targeting two hormones simultaneously — GIP and GLP-1 — to reduce appetite, slow digestion, and help your body use insulin more effectively. Clinical trials showed patients losing an average of 20–22% of their body weight, making it one of the most effective prescription weight loss medications available today.

---

If you've been following the conversation around weight loss medications, you've probably heard the name Zepbound. It launched in late 2023 and quickly became one of the most talked-about — and most in-demand — prescription drugs in the country. But beyond the headlines, what exactly is Zepbound, and is it the right option for you?

This guide breaks down everything you need to know: what Zepbound is approved to treat, how it's dosed, who shouldn't take it, and what important warnings come with it.

---

What Is Zepbound?

Zepbound is the brand name for tirzepatide, a medication manufactured by Eli Lilly and Company. It's delivered as a subcutaneous injection — meaning you inject it just under the skin — once per week.

Tirzepatide belongs to a class of drugs called GIP/GLP-1 receptor agonists. That dual-action mechanism is what sets Zepbound apart from older weight loss medications and even from some of its closest competitors. While drugs like semaglutide (Wegovy, Ozempic) only target GLP-1 receptors, tirzepatide targets both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors at the same time.

The result? Stronger appetite suppression, better blood sugar regulation, and — in clinical trials — greater weight loss than most other medications in its class.

You might also recognize tirzepatide under a different brand name: Mounjaro. Same drug, different brand, different FDA approval. Mounjaro is approved specifically for type 2 diabetes. Zepbound is approved specifically for weight management. (More on that distinction below.)

For a deeper look at the science behind how tirzepatide works in your body, see how Zepbound works.

---

FDA-Approved Uses

The FDA approved Zepbound in November 2023 for the following indication:

Chronic weight management in adults who have:

• A BMI of 30 or greater (classified as obesity), OR
• A BMI of 27 or greater (classified as overweight) plus at least one weight-related comorbidity, such as:
  • Type 2 diabetes
  • High blood pressure (hypertension)
  • High cholesterol (dyslipidemia)
  • Obstructive sleep apnea
  • Cardiovascular disease

Zepbound is intended to be used alongside a reduced-calorie diet and increased physical activity — not as a replacement for lifestyle changes. It's a tool to support those changes, not a shortcut around them.

It's worth noting: in late 2024, the FDA also approved Zepbound for a second indication — moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. This made Zepbound the first medication ever approved specifically for OSA treatment, which was a significant milestone.

---

Common Off-Label Uses

"Off-label" means a doctor prescribes a medication for a purpose other than what the FDA officially approved it for. This is legal, common, and sometimes well-supported by clinical evidence.

For Zepbound and tirzepatide, off-label use most commonly includes:

• Type 2 diabetes management — Mounjaro (tirzepatide) is the on-label option here, but some providers may prescribe Zepbound in specific circumstances
• Non-alcoholic fatty liver disease (NAFLD/MASH) — early research suggests tirzepatide may reduce liver fat
• Polycystic ovary syndrome (PCOS) — often tied to insulin resistance and weight, where tirzepatide may offer benefits
• Cardiovascular risk reduction — ongoing studies are evaluating tirzepatide's effects on heart outcomes in non-diabetic patients with obesity

If your doctor is recommending Zepbound for an off-label use, that's worth a conversation about the current evidence and what alternatives exist.

---

How Is Zepbound Supplied?

Zepbound comes as a prefilled, single-dose autoinjector pen. You inject it once per week, on the same day each week, into your abdomen, thigh, or upper arm.

Available Strengths

Zepbound is available in six dosage strengths:

Each pen comes pre-filled and ready to use. Zepbound does not require mixing, measuring, or drawing up from a vial — which makes it more straightforward to use than some older injectable medications.

Storage

Zepbound pens should be stored in the refrigerator (36°F to 46°F). You can keep a pen at room temperature (up to 86°F) for up to 21 days if needed — useful if you're traveling. Never freeze Zepbound, and keep it away from direct heat and light.

---

Typical Dosing Schedule

Zepbound follows a gradual dose escalation schedule. Starting low and increasing slowly is key — it gives your body time to adjust and significantly reduces the chance of side effects like nausea.

Here's the typical escalation schedule your doctor will likely follow:

• Weeks 1–4: 2.5 mg once weekly (starting dose — not a therapeutic dose, just for tolerability)
• Weeks 5–8: 5 mg once weekly
• After that, your doctor may increase the dose in 2.5 mg increments every 4 weeks as tolerated, up to a maximum dose of 15 mg once weekly

Not everyone needs to reach 15 mg. Some patients achieve their goals at 5 mg or 10 mg, and staying at a lower dose that you tolerate well is often better than pushing to the maximum unnecessarily.

If you miss a dose, take it as soon as you remember — as long as the next scheduled dose is at least 4 days away. If it's less than 4 days until your next dose, skip the missed dose and resume your regular schedule. Never take two doses in one week.

Your doctor will also periodically evaluate whether Zepbound is working for you. If you haven't lost at least 5% of your body weight after 16–20 weeks at a therapeutic dose, your doctor may reassess whether to continue or switch approaches.

---

Who Should NOT Take Zepbound?

Zepbound isn't right for everyone. There are some situations where it's contraindicated — meaning the risks outweigh the benefits, and it should not be used.

Absolute Contraindications

1. Personal or family history of medullary thyroid carcinoma (MTC) Animal studies showed tirzepatide caused thyroid C-cell tumors. The FDA requires a black box warning about this risk (see warnings section below). If you or a first-degree relative has had MTC, Zepbound is not for you.

2. Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) MEN 2 is a genetic condition associated with MTC. For the same reasons above, Zepbound is contraindicated.

3. Serious hypersensitivity to tirzepatide or any ingredient in the formulation If you've had a severe allergic reaction to tirzepatide before — anaphylaxis, angioedema — you should not take Zepbound.

Who Should Use Zepbound With Caution

These aren't hard stops, but they're situations where you and your doctor need to weigh the risks carefully:

• Pregnancy — Zepbound is not recommended during pregnancy. Weight loss during pregnancy can harm a fetus. If you become pregnant while taking Zepbound, stop it and contact your doctor immediately
• Breastfeeding — it's unknown whether tirzepatide passes into breast milk; most providers recommend avoiding it while nursing
• History of pancreatitis — tirzepatide has been associated with pancreatitis; if you've had it before, your doctor will weigh whether this is appropriate
• Diabetic retinopathy — rapid improvements in blood sugar control can temporarily worsen diabetic eye disease
• Severe kidney or liver disease — use with caution; your doctor may monitor you more closely
• Eating disorders — Zepbound's appetite-suppressing effects may complicate treatment in patients with a history of restrictive eating disorders

---

Key Warnings

The FDA requires several important warnings for Zepbound. These aren't meant to scare you — they're meant to make sure you and your doctor are making an informed decision.

⚠️ Black Box Warning: Thyroid C-Cell Tumors

This is the most serious warning and appears at the top of Zepbound's prescribing information.

In rodent studies, tirzepatide caused thyroid C-cell tumors, including medullary thyroid carcinoma. It's not yet known whether this risk applies to humans, but out of caution, Zepbound is contraindicated in people with a personal or family history of MTC or MEN 2.

Tell your doctor right away if you notice any lumps or swelling in your neck, hoarseness, difficulty swallowing, or shortness of breath — these could be signs of thyroid problems.

Pancreatitis

Cases of acute pancreatitis have been reported in people taking tirzepatide. If you develop severe, persistent abdominal pain — especially pain that radiates to your back — stop taking Zepbound and seek medical attention. Pancreatitis is serious and requires prompt treatment.

Hypoglycemia (Low Blood Sugar)

On its own, Zepbound has a low risk of causing low blood sugar. However, if you're taking it alongside insulin or insulin secretagogues (like sulfonylureas), your risk of hypoglycemia increases significantly. Your doctor may need to lower your other diabetes medication doses when starting Zepbound.

Gallbladder Problems

Rapid weight loss of any kind — including with GLP-1 medications — can increase your risk of gallstones or gallbladder inflammation (cholecystitis). If you have upper abdominal pain, fever, or jaundice while taking Zepbound, get evaluated.

Heart Rate Increase

Zepbound can cause a small but noticeable increase in resting heart rate. Your doctor may monitor this, especially if you have existing heart conditions.

Suicidal Ideation and Behavior

This is a required FDA warning for weight management medications as a class. Clinical trials of Zepbound did not show a meaningful signal for this, but you should still let your doctor know if you experience changes in mood, thoughts of self-harm, or new or worsening depression.

Drug Interactions

Zepbound slows gastric emptying (how fast food moves through your stomach), which can affect how quickly your body absorbs other oral medications. This matters especially for time-sensitive drugs like oral contraceptives and certain heart medications. For a full breakdown, see Zepbound drug interactions.

---

A Word on Availability and Cost

Zepbound has been in high demand since its launch, which has led to supply shortages in some areas. Not every pharmacy carries every dose, and some patients have had to call around extensively just to fill their prescription.

If you've run into this problem, you're not alone — it's one of the most common frustrations we hear from patients trying to manage their Zepbound prescriptions.

On cost: Zepbound's list price is approximately $1,060–$1,100 per month without insurance. For patients with commercial insurance who qualify, Eli Lilly's savings card can bring costs down significantly — potentially to as low as $25/month. Patients on Medicare or Medicaid typically do not qualify for manufacturer savings cards, and coverage varies widely by plan.

For a detailed breakdown of cost, insurance coverage, and savings options, check out the other articles in this series.

---

Frequently Asked Questions

Is Zepbound the same as Mounjaro?

They contain the same drug — tirzepatide — but they're different products with different FDA approvals. Mounjaro is approved for type 2 diabetes. Zepbound is approved for chronic weight management. The dosing and delivery device are similar, but they're prescribed for different indications and may have different insurance coverage.

How is Zepbound different from Ozempic or Wegovy?

Ozempic and Wegovy contain semaglutide, which targets only GLP-1 receptors. Zepbound targets both GLP-1 and GIP receptors. That dual mechanism appears to produce greater weight loss on average — clinical trial data showed tirzepatide outperforming semaglutide in head-to-head comparisons, though individual results always vary.

How long do you have to take Zepbound?

Zepbound is approved for chronic weight management — meaning it's intended as a long-term treatment, not a short-term fix. Research shows that most people regain a significant portion of lost weight if they stop taking it. You and your doctor should discuss your long-term plan before starting.

What side effects should I watch for?

The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, and constipation, especially in the early weeks of treatment. These usually improve over time as your body adjusts. For a full breakdown of what to expect, see Zepbound side effects.

---

Need help finding Zepbound in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Zepbound Near You →

---

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →